# CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cd163-as-a-novel-target-gene-of-stat3-is-a-potential-therapeutic-target-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhenguo Cheng,Danhua Zhang,Baocheng Gong,Pengliang Wang,Funan Liu |
| Citations | 51 |
| DOI | 10.18632/oncotarget.20244 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=20244&path%5B%5D=64552 |
| OpenAlex ID | https://openalex.org/W2749074568 |
| PMID | 29152078 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Danhua Zhang](https://scholariq.org/researchers/danhua-zhang/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

## Paper topics

- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Chemokine receptors and signaling](https://scholariq.org/topics/chemokine-receptors-and-signaling/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.